Skip to main content
. 2017 May 17;17(3):363–370. doi: 10.1007/s40268-017-0184-x

Table 5.

Number (%) of subjects reporting drug-related treatment-emergent adverse events

Study 1 Study 2
Test (N = 24) Reference (N = 24) Test (N = 23) Reference (N = 24)
Participants with AEs 1 (4.2) 2 (8.3) 3 (13.0) 3 (12.5)
Number of AEs
 Somnolence 1 (4.2) 0 (0.0) 2 (8.7) 2 (8.3)
 Nausea 1 (4.2) 1 (4.2) 1 (4.3) 1 (4.2)
 Feeling abnormal 0 (0.0) 1 (4.2) 0 (0.0) 0 (0.0)
 Feeling hot 0 (0.0) 0 (0.0) 1 (4.3) 0 (0.0)